title: Coagulation, Fibrinolysis, and Platelet Activation Following Open Surgical or Percutaneous Angioplasty Revascularization for Symptomatic Lower Limb Chronic Ischemia.
abstract: BACKGROUND
  Critical limb ischemia (CLI) is associated with a prothrombotic diathesis that involves a complex balance between the coagulation and fibrinolytic systems. Knowledge of this is essential when considering revascularization procedures but is often overlooked. The aim of this review is to summarize the available literature and provide an overview of the effects of lower limb angioplasty and open surgical revascularization on coagulation, fibrinolysis, and platelet activation.
  
  
  METHODS
  A MEDLINE and EMBASE search was conducted between 1973 and 2014 for articles relating to the effects of revascularization for patients with CLI on the fibrinolytic and coagulation pathways. Studies with a small cohort of patients (<5) were rejected.
  
  
  RESULTS
  Many of the studies included in this analysis had small cohorts. Multiple markers were assessed across the published literature including von Willebrand factor, tissue factor, prothrombin fragments 1 and 2, platelets, soluble platelet selectin, plasminogen activator inhibitor 1, tissue plasminogen activator, and thrombin-antithrombin complex. Percutaneous intervention causes an exaggerated prothrombotic and a disturbed fibrinolytic effect. Surgery seems to cause a similar prothrombotic derangement with reduced fibrinolysis and platelet hyperactivity, but this appears to be maintained for a considerable amount of time postoperatively.
  
  
  CONCLUSIONS
  There is a sparse amount published on the effects of the coagulation and fibrinolytic systems in patients undergoing intervention for CLI. Much of these studies are small, historical, and completely heterogeneous, making it difficult to draw meaningful conclusions. The literature does identify a prothrombotic state in patients with CLI, which appears to be exacerbated by any form of intervention and prolonged in those having surgery. Understanding this may allow us to tailor the intervention offered to patients and prevent limb loss.
authors.affiliation: Department of Vascular Surgery, Leicester Royal Infirmary, Leicester, United Kingdom hsrayt@hotmail.com.
authors.forename: Harjeet S
authors.initials: HS
authors.lastname: Rayt
authors.affiliation: Southmead Hospital, Bristol, United Kingdom.
authors.forename: L
authors.initials: L
authors.lastname: Merker
authors.affiliation: Department of Vascular Surgery, Leicester Royal Infirmary, Leicester, United Kingdom.
authors.forename: Robert S M
authors.initials: RS
authors.lastname: Davies
mesh_terms: D017130:Angioplasty / Q000009:adverse effects; D001777:Blood Coagulation; D016638:Critical Illness; D005342:Fibrinolysis; D006801:Humans; D007511:Ischemia / Q000097:blood / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D035002:Lower Extremity / Q000098:blood supply*; D015539:Platelet Activation; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood / Q000209:etiology; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures / Q000009:adverse effects
keywords: angioplasty; coagulation; fibrinolysis; revascularization